uMedical
Medicines
Substances
Companies
Statistics
Menu
All medicines
Amtagvi
Application withdrawn
Human
Details
EMA number
EMEA/H/C/004741
ATC code
L01XL11
Authorisation
-
Revision
-
EMA page
Therapeutic indication
Treatment of unresectable or metastatic melanoma
MeSH:
Melanoma
Active substances
lifileucel
Marketing Authorisation Holder
Iovance Biotherapeutics B.V.
MAH
Amtagvi | uMedical